发明名称 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases. |
摘要 |
This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor or p56<lck> tyrosine kinase activity, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation. |
申请公布号 |
AP1444(A) |
申请公布日期 |
2005.07.18 |
申请号 |
AP19990001709 |
申请日期 |
1998.05.28 |
申请人 |
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
发明人 |
CHONG WESLEY, K, M.MYERS, MICHAEL, R.;SPADA, ALFRED, P.;WEI HE |
分类号 |
A61K31/47;A61K31/495;A61K31/498;A61K31/5377;A61P9/00;A61P9/10;A61P17/06;A61P19/08;A61P29/00;A61P35/00;A61P35/02;A61P43/00;C07D215/20;C07D215/38;C07D241/42;C07D241/44;C07D241/52;C07D241/54;C07D403/04;C07D405/10;C07D405/12;C07D453/06;(IPC1-7):C07D241/44 |
主分类号 |
A61K31/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|